Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.

Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR.

Schizophr Res. 2014 Feb;152(2-3):325-32. doi: 10.1016/j.schres.2013.12.013. Epub 2014 Jan 11.

PMID:
24418122
[PubMed - in process]
2.

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR.

Mol Psychiatry. 2014 Jan;19(1):20-9. doi: 10.1038/mp.2013.136. Epub 2013 Oct 29. Review.

PMID:
24166406
[PubMed - indexed for MEDLINE]
3.

Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.

da Silva Alves F, Boot E, Schmitz N, Nederveen A, Vorstman J, Lavini C, Pouwels PJ, de Haan L, Linszen D, van Amelsvoort T.

PLoS One. 2011;6(6):e21685. doi: 10.1371/journal.pone.0021685. Epub 2011 Jun 30. Erratum in: PLoS One. 2011;6(8). doi: 10.1371/annotation/805ba3f5-0fd7-41f9-bc2c-31ebf507f05b. Pouwels, Petra [corrected to Pouwels, Petra J].

PMID:
21738766
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE.

Schizophr Bull. 2013 Jan;39(1):120-9. doi: 10.1093/schbul/sbr069. Epub 2011 Jul 11. Review.

PMID:
21746807
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.

Merritt K, McGuire P, Egerton A.

Front Psychiatry. 2013 Nov 26;4:151. doi: 10.3389/fpsyt.2013.00151. Review.

PMID:
24324444
[PubMed]
Free PMC Article
6.

Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.

Horder J, Lavender T, Mendez MA, O'Gorman R, Daly E, Craig MC, Lythgoe DJ, Barker GJ, Murphy DG.

Transl Psychiatry. 2013 Jul 9;3:e279. doi: 10.1038/tp.2013.53.

PMID:
23838890
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia.

Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Koike S, Yahata N, Katsura M, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H.

Schizophr Bull. 2014 Sep;40(5):1128-39. doi: 10.1093/schbul/sbt124. Epub 2013 Sep 10.

PMID:
24023251
[PubMed - in process]
8.

Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.

Ota M, Ishikawa M, Sato N, Hori H, Sasayama D, Hattori K, Teraishi T, Nakata Y, Kunugi H.

Acta Psychiatr Scand. 2012 Jul;126(1):72-8. doi: 10.1111/j.1600-0447.2012.01853.x. Epub 2012 Mar 20.

PMID:
22432602
[PubMed - indexed for MEDLINE]
9.

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN.

Bipolar Disord. 2012 Aug;14(5):478-87. doi: 10.1111/j.1399-5618.2012.01033.x. Review.

PMID:
22834460
[PubMed - indexed for MEDLINE]
10.

Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.

Stone JM.

Curr Pharm Des. 2009;15(22):2594-602. Review.

PMID:
19689330
[PubMed - indexed for MEDLINE]
11.

MR Spectroscopic Studies of the Brain in Psychiatric Disorders.

Maddock RJ, Buonocore MH.

Curr Top Behav Neurosci. 2012 Feb 1. [Epub ahead of print]

PMID:
22294088
[PubMed - as supplied by publisher]
12.

Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.

Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, Milewski R, Walecki J.

Neurosci Lett. 2013 Jun 28;547:37-41. doi: 10.1016/j.neulet.2013.04.051. Epub 2013 May 9.

PMID:
23665527
[PubMed - indexed for MEDLINE]
13.

Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study.

Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M, Garcia-Campayo J.

Acta Psychiatr Scand. 2012 Aug;126(2):115-25. doi: 10.1111/j.1600-0447.2011.01820.x. Epub 2011 Dec 30.

PMID:
22211322
[PubMed - indexed for MEDLINE]
14.

Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia.

Falkenberg LE, Westerhausen R, Craven AR, Johnsen E, Kroken RA, L Berg EM, Specht K, Hugdahl K.

Neuroimage Clin. 2014 Apr 2;4:576-84. doi: 10.1016/j.nicl.2014.03.014. eCollection 2014.

PMID:
24749064
[PubMed - in process]
Free PMC Article
15.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
[PubMed - indexed for MEDLINE]
16.

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.

Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.

Pharmacopsychiatry. 2011 Jun;44(4):148-57. doi: 10.1055/s-0031-1279739. Epub 2011 Jun 27.

PMID:
21710405
[PubMed - indexed for MEDLINE]
17.

Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.

Antuono PG, Jones JL, Wang Y, Li SJ.

Neurology. 2001 Mar 27;56(6):737-42.

PMID:
11274307
[PubMed - indexed for MEDLINE]
18.

Proton magnetic resonance spectroscopy changes after antipsychotic treatment.

Szulc A, Galinska-Skok B, Waszkiewicz N, Bibulowicz D, Konarzewska B, Tarasow E.

Curr Med Chem. 2013;20(3):414-27. Review.

PMID:
23157634
[PubMed - indexed for MEDLINE]
19.

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.

Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M, Kaufmann CA.

Psychiatry Res. 2000 May 15;98(3):163-75.

PMID:
10821999
[PubMed - indexed for MEDLINE]
20.

Brain glutamine and glutamate levels in patients with liver cirrhosis: assessed by 3.0-T MRS.

Sawara K, Kato A, Yoshioka Y, Suzuki K.

Hepatol Res. 2004 Sep;30(1):18-23.

PMID:
15341770
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk